Deborah Brown - Net Worth and Insider Trading
Deborah Brown Net Worth
The estimated net worth of Deborah Brown is at least $62,117 dollars as of 2024-09-20. Deborah Brown is the Director of Oncolytics Biotech Inc and owns about 30,827 shares of Oncolytics Biotech Inc (TSX:ONC) stock worth over $39,767. Deborah Brown is also the Director of Cardiol Therapeutics Inc and owns about 7,450 shares of Cardiol Therapeutics Inc (TSX:CRDL) stock worth over $22,350. Details can be seen in Deborah Brown's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Deborah Brown has not made any transactions after 2020-01-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Deborah Brown
Deborah Brown Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Deborah Brown owns 2 companies in total, including Oncolytics Biotech Inc (TSX:ONC) , and Cardiol Therapeutics Inc (TSX:CRDL) .
Click here to see the complete history of Deborah Brown’s form 4 insider trades.
Insider Ownership Summary of Deborah Brown
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:ONC | Oncolytics Biotech Inc | 2020-01-06 | Director |
| TSX:CRDL | Cardiol Therapeutics Inc | 2019-10-29 | Director |
Deborah Brown Latest Holdings Summary
Deborah Brown currently owns a total of 2 stocks. Among these stocks, Deborah Brown owns 30,827 shares of Oncolytics Biotech Inc (TSX:ONC) as of January 6, 2020, with a value of $39,767 and a weighting of 64.02%. Deborah Brown also owns 7,450 shares of Cardiol Therapeutics Inc (TSX:CRDL) as of October 29, 2019, with a value of $22,350 and a weighting of 35.98%.
Latest Holdings of Deborah Brown
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:ONC | Oncolytics Biotech Inc | 2020-01-06 | 30,827 | 1.29 | 39,767 |
| TSX:CRDL | Cardiol Therapeutics Inc | 2019-10-29 | 7,450 | 3.00 | 22,350 |
Holding Weightings of Deborah Brown
Deborah Brown Form 4 Trading Tracker
According to the SEC Form 4 filings, Deborah Brown has made a total of 1 transactions in Oncolytics Biotech Inc (TSX:ONC) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Oncolytics Biotech Inc is the sale of 14,000 shares on January 6, 2020, which brought Deborah Brown around $66,996.
According to the SEC Form 4 filings, Deborah Brown has made a total of 2 transactions in Cardiol Therapeutics Inc (TSX:CRDL) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Cardiol Therapeutics Inc is the acquisition of 550 shares on October 29, 2019, which cost Deborah Brown around $1,865.
Insider Trading History of Deborah Brown
- 1
Deborah Brown Trading Performance
GuruFocus tracks the stock performance after each of Deborah Brown's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Deborah Brown is 19.91%. GuruFocus also compares Deborah Brown's trading performance to market benchmark return within the same time period. The performance of stocks bought by Deborah Brown within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Deborah Brown's insider trading performs compared to the benchmark.
Performance of Deborah Brown
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 14.16 | | | | | |
| Relative Return to S&P 500(%) | 10.56 | | | | | |
Deborah Brown Ownership Network
Deborah Brown Owned Company Details
What does Oncolytics Biotech Inc do?
Who are the key executives at Oncolytics Biotech Inc?
Deborah Brown is the Director of Oncolytics Biotech Inc. Other key executives at Oncolytics Biotech Inc include Director & Senior Officer Matthew Coffey , and Senior Officer Kirk Look .
Oncolytics Biotech Inc (TSX:ONC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Oncolytics Biotech Inc (TSX:ONC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Oncolytics Biotech Inc (TSX:ONC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Oncolytics Biotech Inc (TSX:ONC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oncolytics Biotech Inc Insider Transactions
Deborah Brown Mailing Address
Above is the net worth, insider trading, and ownership report for Deborah Brown. Currently GuruFocus does not have mailing address information for Deborah Brown.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
